The aim of this study is to determine the clinical, morphological, and immunophenotypical presentation of 9 cases of a particular type of canine T-cell lymphoma/leukemia. The morphological presentation was a diffuse infiltration of small, medium-sized, or large blast cells with eccentric nuclei, hyperbasophilic cytoplasm, and a juxtanuclear, pale cytoplasmic area, giving a plasmacytoid appearance and suggesting a Bcell morphology. Surprisingly, all 9 cases were of T-cell phenotype (CD3 ϩ ). Among the 7 immunophenotyped cases, 4 were CD4 Ϫ /CD8 ϩ , 2 CD8 ϩ /CD4 ϩ , and 1 CD4 ϩ /CD8 Ϫ . The median Ki-67 index was 65.7%, which placed this lymphoma in the high-grade group. This type of lymphoma/leukemia was found in dogs between 1 and 11 years of age, with a median age of 5.8. The male-female ratio was 0.8 for a reference population of 1.04. The most significant clinical findings were lymphadenopathy either generalized or localized in all cases, a mediastinal mass in 4 cases, bone marrow involvement in 7 cases, hypercalcemia in 4 cases, along with an aggressive clinical course and a poor response to chemotherapy in all cases, with a median disease-free survival time of 3 months.
Introduction
Canine non-Hodgkin's lymphomas (NHLs), according to human terminology, represent a heterogeneous group of highly aggressive tumors often resistant to therapy. Hodgkin's lymphoma has not yet been recognized in the dog. The recent human classifications of NHLs by the Revised European American lymphoma (REAL) 17 and the World Health Organization (WHO) 30 take into account epidemiological, clinical, phenotypical, and genetic criteria, allowing determination of clinico-morphological entities with distinct prognosis and therapeutic schemes. Moreover, they identify some infectious agent-associated entities such as adult T-cell leukemia/lymphoma (ATLL), associated with the human T-cell lymphotropic virus (HTLV I); Burkitt's lymphoma and nasal T-cell lymphoma, both associated with the Epstein-Barr virus; and gastric lymphoma, closely linked to infection by Helicobacter pylori. 31 Classifications of canine NHLs 1, [5] [6] [7] 14, 24, 26, 29 have been based on the successive human classifications. 4, 19 The latest studies 11, 32 have used morphological and immunological criteria, according to the updated Kiel classification 27 and have tended to identify clinico-morphological entities following the REAL and the WHO schemes. 13 The purpose of this article is to report 9 cases of unusual canine T-cell neoplasms, on the basis of morphological, immunological, and clinical criteria. The recognition of a new provisional entity among canine peripheral T-cell neoplasms is discussed.
Materials and methods
Animals. Among a series of 253 cases of canine lymphoid neoplasms referred to the laboratory of Hematology-Cytology-Immunology of the Lyon Veterinary School, Lyon, France, between 1997 and 2001, all subjected to immunophenotyping, 9 cases of an unusual type of lymphoma/leukemia were diagnosed. Each diagnosis was on the basis of a cytological examination of either fine-needle aspirates (FNAs) or touch imprint and biopsy specimens from at least 1 enlarged lymph node, except in 4 cases where, on the owners' request, there was only an FNA examination. Bone marrow aspiration was performed in all cases. The 9 cases were classified as lymphoma when the dogs presented with a mass lesion and 25% or fewer lymphomatous cells in the bone marrow and as leukemia with more than 25% of bone marrow infiltration.
Clinical and biological evaluation. All the dogs were given a complete physical examination, with additional abdominal ultrasonography and thoracic radiography. A complete blood count and a serum biochemical profile (blood urea nitrogen, serum creatinine, alanine aminotransferase, alkaline phosphatase, calcium, and serum protein) were carried out in all cases. Eight of the 9 dogs were treated by chemotherapy. One case (No. 4) was euthanized on the owner's request. The protocol used L-asparaginase, vincristine, cyclophosphamide, and prednisolone, as shown in Table 1 . Disappearance of all measurable tumor was considered as a complete response and the disease-free survival time (DFST) as the time between the initial diagnosis and the first relapse (recurrence of the adenopathy). Cytological evaluation. Cytological samples were airdried, and stained by the May-Grünwald-Giemsa (MGG) procedure. The morphological classification criteria were based on the cell size (''small,'' ''medium,'' or ''large,'' i.e., nuclei smaller than, equal to, or larger than 2 red blood cells); the shape of the nuclei; the density of the chromatin; the number, size, and distribution of the nucleoli; and the volume and basophilia of the cytoplasm.
Histological evaluation. Biopsy specimens from enlarged lymph nodes in 5 cases and from an additional lytic bone lesion in 1 case were fixed in 10% neutral buffered formalin at room temperature for 48 hr, and embedded in paraffinwax. Sections of 2 m thickness were cut and stained with hematoxylin and eosin (HE) and Giemsa for light-microscopic examination. The mitotic index was estimated in histological specimens, by scanning 10 fields at 400ϫ, counting the mitotic figures, and calculating the medium number. A low mitotic index was defined as 0-2 mitoses/field, medium as 3-5 mitosis/field, and high as 6 or more mitoses/field. Immunophenotypic evaluation. To classify the cases as Bor T-cell lymphomas, immunophenotyping was performed on fresh or frozen FNA or on paraffin-wax sections, with antibodies raised against human antigens but cross-reacting with the equivalent canine antigens, i.e., a polyclonal rabbit antibody against CD3 a as a pan-T marker 10 and a monoclonal antibody directed against CD79a a as a pan-B marker. 22, 23 A standard avidin-biotin-immunoperoxidase procedure was performed with commercial reagents. b After the removal of paraffin with xylene, the histological slides were treated with the Endo/Blocker reagent for 5 min at room temperature to suppress endogenous phosphatase-and peroxidase-like enzyme activities (undesirable background staining). Then, a pretreatment for antigen retrieval (proteolytic enzyme mixture c and 2 min in a pressure cooker, at 112 C, and 50 ϫ 10 3 Pa) was performed. Cytological slides were fixed with pure acetone for 5 min and hydrogen peroxide diluted 1 in 10, was applied for 3 min, to block endogenous enzymatic activity. Then, both histological and cytological slides were covered for 10 min with a blocking reagent (tissue conditioner with proteins and nonimmune immunoglobulins to block nonspecific antigenic sites), then incubated for 1 hr at room temperature with primary antibodies diluted 1 in 50. After 2 rinses in phosphate-buffered saline (PBS), a bioti-nylated secondary antibody (reagent 1A) preincubated with normal dog serum was applied to each slide for 20 min at room temperature. After 2 washes, streptavidin-peroxidase (reagent 2) was applied for 20 min at room temperature. After 2 rinses in PBS, 3-3Ј diaminobenzidine was applied for 15 min at room temperature as a chromogen (reagent 3). The sections were then washed in distilled water and counterstained with Mayer hematoxylin. Nonimmune serum was used as a negative control and a normal canine lymphoid sample as a positive control.
For immunophenotyping by CD4 and CD8 (monoclonal anti-canine T-cells), d cytological preparations were either used immediately or stored at Ϫ80 C, except in 2 cases where there was insufficient cytological material. Immunolabeling was then carried out according to the same standard avidin-biotin-immunoperoxidase procedure, without any pretreatment, and at a 1 in 10 dilution of primary antibody.
Immunolabeling with the MiB-1, a primary monoclonal antibody specific to the Ki-67 nuclear antigen, a was performed in 5 cases, using the same procedure as for the paraffin-wax sections (1 to 50 dilution, incubation for 1 hr at room temperature). The proliferation index, Ki-67, was then determined at 1,000ϫ by counting the number of Ki-67 ϩ cells/1,000 cells. The counting was carried out on the tissue sections in zones that showed the highest degree of proliferation. Cells were considered to be Ki-67 ϩ if a brown staining of the nuclei, either focal or diffuse, or both, was observed, without distinction between the 2 types of labelling. 12
Results
Incidence, morphology, and immunophenotyping. The 9 cases of plasmacytoid T-cell lymphoma/leukemia of the 253 cases examined over the 4 years represent 3.5% of the total population. From the cytological point of view, the lymphomatous population included a majority of medium-sized-cells with small and large cells in varying proportions, irregularly visible multiple nucleoli, and relatively abundant highly basophilic cytoplasm ( Fig. 1 ). This abundant highly basophilic cytoplasm, with eccentric nuclei, occasional binucleation (Fig. 2) , and juxtanuclear pale cytoplasmic area, provide a plasmacytoid appearance. The nuclei were eccentrically located, round or slightly notched, and in 1 case, occasionally flower-shaped ( Fig. 1 ). Multilobulated nuclear outlines ( Fig. 3a ) and flower-shaped aspect (Fig. 3b) were found in blood, in another case. The chromatin was irregularly clumped in the smaller cells, which accentuated the plasmacytoid appearance, and fine and dispersed in larger cells. Several nucleoli were generally visible though not prominent. Tingible-body macrophages and normal residual plasma cells were often present in the background.
Histologically, all the cases had a diffuse and monotonous infiltration of medium-sized cells in the majority, with a varying number of small and large cells and the occasional binucleated cell (Figs. 4, 5). With Giemsa staining, the irregularly clumped chromatin, the volume and basophilia of the cytoplasm, with a pale juxtanuclear area, were particularly obvious and constituted a characteristic feature of this particular type of T-cell neoplasm (Fig. 6 ). Five cases had a high mitotic index, from 7.5 to 11.8 (median 9.7) ( Table 2) and a strongly marked starry-sky pattern except for case No. 8 (mitotic index 7.5), where it was present but lighter than in the others. The hyperplasia of the postcapillary venules was generally moderate, again with exception of case No. 8, where it was marked. Frequent normal residual plasma cells were observed in the background.
All 9 cases expressed a T-cell phenotype (CD3 ϩ / CD79a Ϫ ). Among the 7 cases evaluated for CD4 and CD8 expression, a CD8 ϩ phenotype was expressed in 6, including 4 CD4 Ϫ /CD8 ϩ , 2 CD4 ϩ /CD8 ϩ lympho-mas, and only 1 CD4 ϩ /CD8 Ϫ . None were CD4 Ϫ /CD8 Ϫ ( Table 3 ).
The 5 cases evaluated for Ki-67 expression had an index ranging from 50% to 82% (median 66%), as shown in Table 2 .
Epidemiological, clinical and biological features. These T-cell lymphoma/leukemia were diagnosed in animals between 1 and 11 years of age, with a median age of 5.8. The male-female ratio was 0.8 for a reference population of 1.04 ( Table 4 ).
The dogs were presented for examination for a variety of clinical signs such as weakness, weight loss, gastrointestinal signs, or dyspnea, which had developed quickly, i.e., within 1 week in most cases (Table  4 ). At the time of examination, all the cases presented a persistent lymphadenopathy, generalized in 7 cases and localized in 2. One animal (No. 4) presented for acute lameness of the left forelimb was found to have a left superficial cervical adenomegaly with a lymphomatous lytic bone lesion of the scapula. Hepatospleno- megaly was present in 6 cases and a mediastinal mass in 4 ( Table 4 ). Bone marrow infiltration, ranging from 18% to 95% of lymphomatous cells was found in 7 cases, with 4 cases (cases nos. 2, 5, 6, 9) defined as leukemia with a marrow infiltration of more than 25%. Only a few circulating lymphomatous cells were observed in the blood in 3 of these 4 cases. Five cases (cases nos. 1, 3, 4, 7, 8) were classified as lymphoma. Four dogs had anemia and/or thrombocytopenia or both. The biochemical profile was generally within the reference values, except for evidence of hypercalcemia in 4 cases (Table 5 ). From a therapeutic point of view, a complete clinical remission occurred in all 8 treated cases, giving a median DFST of 3 months, with a range of 1-6 months ( Table 4 ).
Discussion
The classification of canine lymphoma is constantly developing. Classifications based on morphology, as in the Working Formulation, or morphology and immunophenotype as in the updated Kiel classification, 27 now attempt to define clinico-pathological entities with clinical and prognostic relevance, close to the REAL and WHO classifications. 16, 17, 21, 30 However the lack of sufficient epidemiological, phenotypical, and genetic information in veterinary medicine means that it is difficult to make full use of these classifications. Morphological and clinical studies of the various canine NHLs, including rare variants, are clearly important for the future growth of knowledge about this group of tumors and will lead to more rational classification. As in human medicine, 9, 20, 21, 27, 31 the morphological presentation of canine lymphoma may be suggestive of their phenotype. 13 In that way, the high-grade centroblastic polymorphic B-cell lymphomas of the updated Kiel classification (included in the category of Diffuse Large B-cell Lymphoma of the REAL and WHO classifications), which are in a majority in all the recent canine studies, 11, 33 are morphologically characterized by a mixture of small, medium and large blastic cells, with highly nucleolated nuclei and basophilic cyto- plasm, strongly suggesting the B-cell phenotype. In any case they appear to differ cytologically from the high-grade medium-sized and large T-cell lymphomas, which mostly belong to the pleomorphic category, 11, 13, 33 and are characterized by an irregular nucleus and pale cytoplasm. The category of T-cell neoplasm described in this study is particularly surprising and striking on the basis of its morphological characteristics with abundant highly basophilic cytoplasm, eccentric nuclei, irregularly clumped chromatin in the smaller cells, occasional binucleation, and juxtanuclear pale cytoplasmic area, providing a plasmacytoid appearance and suggesting B-cell lineage. However, the presence of some irregular nuclei among the whole neoplastic population, normal plasma cells in the background, and the lack of the various cell components found in the polymorphic centroblastic B-cell lymphomas, i.e., immunoblasts, centroblasts, and macronucleolated medium-sized cells, 11 suggest a T-phenotype.
Anyway, the precise determination of the immunophenotype was essential to the identification of this lymphoma. Morphology, mitotic index (median 9.7), and proliferation Ki-67 index (median 66%), as reported in previous studies, 11, 12 clearly indicated that this lymphoma/leukemia belonged to the high-grade and, more precisely, to the most highly proliferative category, These neoplasms have been termed unclassifiable high-grade plasmacytoid lymphomas in 2 previous veterinary studies, 11, 13 but have not been recognized by other veterinary authors. An earlier study 33 found an unexpectedly high frequency of lymphomas with Bcell morphology and T-cell phenotype, but they did not describe such characteristic cytological criteria; fur-thermore, in this same study, 33 the use of nonspecific T-cell markers for some cases led to a difficult interpretation of the whole morphological data. The morphological description of these 9 cases of canine T-cell lymphoma/leukemia may come close to some sporadic cases in human medicine; 1 study published in 1989 25 reported 2 cases of plasmacytoid T-cell lymphoma unassociated with a chronic myeloproliferative disorder (unlike the previously described myeloproliferative disorder-associated ''plasmacytoid'' NHLs, which now seem to be of histiocytic origin). 8, 18, 27 Another study 9 reported 2 cases of ''peripheral T-cell lymphomas with a plasmacytoid appearance.'' Furthermore, this morphological presentation reminds of some morphological characteristics of the human ATLL, with basophilic cells and a floral nuclear aspect. But most of the cases described here did not have the pleomorphic nuclei frequently found in human ATLL. 9, 21 So, at the present time, they can not be compared with any definite equivalent in humans. 2, 3, 9, 15, [19] [20] [21] In the new human classifications, the precise determination of the immunophenotype constitutes an additional, and sometimes essential, criterion for the recognition of the various entities, e.g., among the T-cell neoplasms, the typical CD4 ϩ phenotype of mycosis fungoides, and ATLL, and, on the other hand, the CD8 ϩ phenotype of the subcutaneous panniculitis-like T-cell lymphoma. 21 In the present study, the high frequency of a CD8 ϩ phenotype may constitute an additional reason to consider this entity as distinct.
Finally, to apply the latest clinico-morphological REAL and WHO human classifications, it was important to collect clinical features of this morphological subtype, because, even though the number of cases was too small for the results to be statistically significant, clinical presentation is as important as morphological features for the identification of the various NHLs, especially the T-cell lymphomas. 2, 3, 19, 21, 30, 31 On the one hand, regarding the strongly marked lymphadenopathy, which was always present and most often generalized, and the frequent hepatosplenomegaly, this type of lymphoma could be said to resemble the majority of canine lymphomas, whatever their type be 14, 28, 32 and also the human peripheral T-cell lymphomas. 20, 31 In addition, hypercalcemia observed in this study has been associated with T-cell lymphomas in dogs. 34 On the other hand, its distinctive clinical features were first, the aggressive clinical course, with severe clinical signs developing very quickly (1 week), unlike that of most canine lymphomas, which consists of a generalized lymphadenopathy in patients whose general condition is otherwise satisfactory at the time of diagnosis 28, 32 ; second, a frequent mediastinal mass (4 out of 9 cases), similar to those found in lymphoblastic lymphomas, both in humans 20,21,31 and dogs 13 ; and third, the frequency and severity of bone marrow involvement, which constitutes another common point with the lymphoblastic lymphomas and which explains the denomination of plasmacytoid T-cell lymphoma/ leukemia. It is in keeping with the denomination of several categories of human lymphoid neoplasms of the REAL and new WHO classifications, as the B-cell chronic lymphocytic leukemia/B-cell small-lymphocytic lymphoma, the Burkitt's lymphoma/leukemia, and the HTLV 1-associated ATLL. 20, 21, 31 These neoplasms group both lymphomas and lymphoid leukemias, because both solid and circulating phases are present in many tumors and distinction between them appears artificial. According to this new human terminology, when the process is confined to a mass lesion with 25% or fewer lymphomatous cells in the marrow, the diagnosis is lymphoma; when there is extensive blood and marrow involvement, leukemia is the term used. Thus, 5 cases were classified as plasmacytoid lymphoma and 4 as plasmacytoid leukemia. Surprisingly, for these 4 leukemic cases, the number of circulating neoplastic cells did not correlate with the degree of bone marrow involvement, as in human ATLL. 21 In veterinary as in human medicine, new concepts and, consequently, newly recognized diseases are constantly arising, and they are often difficult to classify. This study described a T-cell lymphoma/leukemia, as a provisional entity on the basis of its aggressive clinical course, frequent mediastinal and leukemic presentation, plasmacytoid morphology, and mostly CD8 ϩ phenotype. At present, it cannot be compared with any other entity in the REAL and WHO human classifi-cations, even if it displays some similarity with the human ATLL. Whether it turns out to be a subtype of the unspecified peripheral T-cell lymphoma as described in the REAL and WHO classifications, or comes to be regarded as a separate entity, will depend on the obtention of more accurate clinical and phenotypical data, and, if possible, on genetic and epidemiological considerations.
